ArticleACS omega2026
Elucidating the Covalent Binding of Ottelione A and Withaferin A at the Colchicine Site of β‑Tubulin.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ottelione A (OTT) and withaferin A (WIT) are natural products known to induce microtubule depolymerization by covalently modifying β-tubulin within the colchicine binding site (COLbs). Experimental evidence suggests that both compounds primarily react with βCys239 through Michael-type additions. In this work, orbital-weighted dual descriptor analysis, relative stability of methyl thiolate adducts, ensemble covalent docking, and molecular dynamics simulations were employed to investigate their reactivity and covalent binding modes. While initial reactivity analysis identified multiple electrophilic centers in both ligands, OTT shows a thermodynamic preference for 1,6-addition products due to hyperconjugative stabilization, whereas WIT favors 1,4-addition products over endergonic 1,2-addition. Docking and molecular dynamics simulations are consistent with these observations, as OTT preferentially forms 1,6-Michael adducts within the COLbs, while WIT forms 1,4-Michael adducts and can adopt an alternative conformation oriented toward the αβ-tubulin interface. Notably, this pose promotes displacement of the β-T7 loop and increased solvent exposure of the hydrophobic COLbs pocket, suggesting a potential structural basis for tubulin destabilization. Overall, this study provides molecular insight into the covalent interaction of OTT and WIT with β-tubulin and suggests structural features underlying their microtubule-destabilizing activity.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.